2280
H.E. Bartrum et al. / Tetrahedron 69 (2013) 2276e2282
281.0600 (MþNa, C15H14NaO2S requires 281.0607). Spectroscopic
m), 1.74e1.62 (2H, m), 1.47e1.22 (6H, m); dC (100 MHz; CDCl3) 164.4
(C]O), 145.2 (C), 133.6 (C), 130.3 (CH), 130.0 (CH), 129.6 (CH), 129.2
(CH), 128.5 (CH), 128.2 (C), 75.5 (CH), 75.2 (CH), 31.2 (CH2), 31.1
(CH2), 25.2 (CH2), 23.5 (CH2), 25.4 (CH2) and 21.7 (CH3); m/z (ESI)
found 395.1298 (MþNa, C21H24NaO4S requires 395.1288).
data matches that previously reported.29
3.3.2. Cyclohexyl 2-phenyl-2-(phenylsulfanyl)acetate, 2b. Following
general flow method A, tosylhydrazone 1b gave, after purification
by column chromatography (1% EtOAc/petrol) compound 2b
(52 mg, 64%) as a colorless oil. Rf 0.7 (40% EtOAc/petrol); nmax
(CHCl3)/cmꢂ1 2940, 2861, 1726, 1584, 1496, 1483, 1454, 1440, 1352,
1304, 1286, 1149, 1120, 1089, 1075, 1037, 1010, 976; dH (400 MHz;
CDCl3) 7.48e7.44 (2H, m), 7.40e7.36 (2H, m), 7.34e7.23 (6H, m),
4.91 (1H, s), 4.80e4.72 (1H, m), 1.75e1.68 (2H, m), 1.66e1.59 (2H,
m), 1.51e1.43 (1H, m), 1.39e1.25 (5H, m); dC (100 MHz; CDCl3) 170.0
(C), 136.0 (C), 134.2 (C), 132.5 (CH), 129.0 (CH), 128.7 (CH), 128.6
(CH), 128.3 (CH), 127.9 (CH), 74.2 (CH), 56.6 (CH), 31.4 (CH2), 31.3
(CH2), 25.4 (CH2), 23.6 (CH2), 23.5 (CH2); m/z (ESI) found 349.1244
(MþNa, C20H22NaO2S requires 349.1233).
3.3.7. Ethyl 2-(4-nitrophenyl)-2-tosylacetate, 3c. Following general
flow method B, tosylhydrazone 1c gave, after purification by col-
umn chromatography (10% EtOAc/petrol) compound 3c (58 mg,
64%) as colorless needles, mp 122e124 ꢀC. Rf 0.6 (40% EtOAc/pet-
rol); nmax (CHCl3)/cmꢂ1 2984, 2940, 2869, 1741, 1607, 1597, 1392,
1370, 1351, 1326, 1306, 1144, 1128, 1083, 1018, 908, 875, 860; dH
(400 MHz; CDCl3) 8.17 (2H, d, J 8.8), 7.65 (2H, d, J 8.8), 7.54 (2H, d, J
8.2), 7.28 (2H, d, J 8.2), 5.22 (1H, s), 4.28e4.16 (2H, m), 2.44 (3H, s),
1.22 (3H, t, J 7.2); dC (100 MHz; CDCl3) 164.0 (C]O), 148.5 (C), 146.1
(C), 134.9 (C), 133.2 (C), 131.5 (CH), 129.8 (CH), 129.7 (CH), 123.5
(CH), 74.5 (CH), 63.0 (CH2), 21.8 (CH3) and 13.9 (CH3); m/z (ESI)
found 364.0846 (MþH, C17H18NO6S requires 364.0849). Found
386.0658 (MþNa, C17H17NNaO6S requires 386.0669).
3.3.3. Ethyl 2-(4-nitrophenyl)-2-(phenylsulfanyl)acetate, 2c. Follo-
wing general flow method A, tosylhydrazone 1c gave, after purifi-
cation by column chromatography (3% EtOAc/petrol) compound 2c
(40 mg, 50%) as a colorless oil. Rf 0.3 (20% EtOAc/petrol); nmax
(CHCl3)/cmꢂ1 2984, 1732, 1607, 1530, 1493, 1645, 1369, 1349, 1322,
1290, 1148, 1111, 1095, 1068, 1025, 859; dH (400 MHz; CDCl3) 8.16
(2H, d, J 8.8), 7.58 (2H, d, J 8.8), 7.35 (2H, dd, J 7.2 and 1.6), 7.30e7.26
(3H, m), 4.92 (1H, s), 4.21e4.12 (2H, m), 1.20 (3H, t, J 7.2); dC
(100 MHz; CDCl3) 169.4 (C),147.8 (C),143.4 (C),133.7 (CH),132.4 (C),
129.7 (CH), 129.3 (CH), 128.9 (CH), 123.9 (CH), 62.4 (CH2), 56.0 (CH),
14.1 (CH3); m/z (ESI) found 340.0611 (MþNa, C16H15NNaO4S re-
quires 340.0614).
3.3.8. Isobutyl 2-phenyl-2-tosylacetate, 3e. Following general flow
method B, tosylhydrazone 1e gave, after purification by column
chromatography (8% EtOAc/petrol) compound 3e (70 mg, 81%) as
colorless needles, mp 66e68 ꢀC. Rf 0.8 (40% EtOAc/petrol); nmax
(CHCl3)/cmꢂ1 2959, 2939, 2876, 1732, 1597, 1456, 1396, 1378, 1348,
1421, 1126, 1083, 1018, 998, 969, 945, 868; dH (400 MHz; CDCl3)
7.50e7.46 (2H, m), 7.39e7.34 (3H, m), 7.31e7.26 (2H, m), 7.22e7.20
(2H, m), 5.08 (1H, s), 3.97 (1H, dd, J 10.6 and 7.0), 3.90 (1H, dd, J 10.6
and 7.0), 2.40 (3H, s), 1.92 (1H, app nonet, J 7.0), 0.88 (6H, d, J 7.0); dC
(100 MHz; CDCl3) 165.1 (C]O),145.4 (C), 133.7 (C), 130.4 (CH), 130.1
(CH), 129.7 (CH), 129.3 (CH), 128.7 (CH), 128.2 (CH), 75.5 (CH), 72.6
(CH2), 27.7 (CH), 21.8 (CH3) and 19.1 (CH3); m/z (ESI) found 369.1135
(MþNa, C19H22NaO4S requires 369.1131).
3.3.4. Ethyl 4-phenyl-2-(phenylsulfanyl)butanoate, 2d. Following
general flow method A, tosylhydrazone 1d gave, after purification
by column chromatography (4% EtOAc/petrol) compound 2d
(43 mg, 51%) as a colorless oil. Rf 0.5 (20% EtOAc/petrol); nmax
(CHCl3)/cmꢂ1 3087, 2983, 2938, 2862, 1723, 1604, 1584, 1496, 1483,
1455, 1370, 1304, 1148, 1094, 1068, 1026, 864; dH (400 MHz; CDCl3)
7.46e7.43 (2H, m), 7.34e7.25 (5H, m), 7.23e7.21 (3H, m), 4.16e4.10
(2H, m), 3.63 (1H, t, J 7.0), 2.77 (2H, t, J 7.6), 2.27e2.17 (1H, m),
2.12e2.03 (1H, m), 1.19 (3H, t, J 6.8); dC (100 MHz; CDCl3) 172.2 (C),
140.7 (C), 133.3 (C), 133.1 (CH), 129.0 (CH), 128.7 (CH), 128.6 (CH),
128.1 (CH), 126.3 (CH), 61.3 (CH2), 50.1 (CH), 33.3 (CH2), 33.2 (CH2),
14.2 (CH3); m/z (ESI) found 301.1258 (MþH, C18H21O2S requires
301.1257). Found 323.1070 (MþNa, C18H20NaO2S requires
323.1076).
3.3.9. Allyl 2-phenyl-2-tosylacetate, 3f. Following general flow
method B, tosylhydrazone 1f gave, after purification by column
chromatography (10% EtOAc/petrol) compound 3f (68 mg, 82%) as
colorless needles, mp 74e76 ꢀC. Rf 0.7 (40% EtOAc/petrol); nmax
(CHCl3)/cmꢂ1 2929, 1738, 1650, 1598, 1495, 1456, 1365, 1341, 1321,
1126, 1083, 1043, 1019, 987, 944, 869; dH (400 MHz; CDCl3)
7.49e7.47 (2H, m), 7.38e7.26 (5H, m), 7.23e7.20 (2H, m), 5.84 (1H,
ddt, J 16.8, 10.4 and 6.0), 5.30 (1H, app dq, J 16.8 and 1.6), 5.23 (1H,
app dq, J 10.4 and 1.2), 5.11 (1H, s), 4.66e4.64 (2H, m), 2.41 (3H, s);
dC (100 MHz; CDCl3) 164.7 (C]O), 145.4 (C), 133.5 (C), 131.0 (CH),
130.4 (CH), 130.1 (CH), 129.8 (CH), 129.3 (CH), 128.7 (CH), 128.0 (C),
119.5 (CH2), 75.4 (CH), 67.0 (CH2) and 21.8 (CH3); m/z (ESI) found
353.0832 (MþNa, C18H18NaO4S requires 353.0818).
3.3.5. Methyl 2-phenyl-2-tosylacetate, 3a. Following general flow
method B, tosylhydrazone 1a gave, after purification by column
chromatography (12% EtOAc/petrol) compound 3a (55 mg, 72%) as
colorless needles, mp 122e124 ꢀC. Rf 0.6 (40% EtOAc/petrol); nmax
(CHCl3)/cmꢂ1 2955, 2928, 1746, 1598, 1495, 1456, 1348, 1321, 1127,
1083, 1007, 908, 868; dH (400 MHz; CDCl3) 7.48e7.45 (2H, m),
7.40e7.25 (5H, m), 7.23e7.20 (2H, m), 5.09 (1H, s), 3.77 (3H, s), 2.41
(3H, s); dC (100 MHz; CDCl3) 165.5 (C]O), 145.5 (C), 133.4 (C), 130.4
(CH), 130.1 (CH), 129.8 (CH), 129.3 (CH), 128.7 (CH), 128.1 (C), 75.3
(CH), 53.3 (CH3), 21.8 (CH3); m/z (ESI) found 327.0676 (MþNa,
C16H16NaO4S requires 327.0662). 1H NMR data matches those pre-
viously reported.30
3.3.10. Cyclohexyl 2-phenyl-2-(phenylsulfonyl)acetate, 4a. To a stir-
red solution of cyclohexyl 2-phenyl-2-(phenylsulfanyl)acetate, 2b
(107 mg, 0.33 mmol) in CH2Cl2 (9 mL) was added mCPBA (170 mg,
0.98 mmol) and the reaction was stirred at room temperature for
3 h (until TLC analysis indicated complete consumption of starting
material). Sodium thiosulfate (5 mL, satd) was added and the re-
action was stirred for a further 15 min before the organic layer was
separated and the aqueous layer extracted with CH2Cl2 (3ꢁ10 mL).
The combined organic fractions were dried (MgSO4), filtered, and
concentrated in vacuo. The crude residue was purified by column
chromatography (5% EtOAc/petrol) to give the title compound, 4a
(116 mg, 98%) as a colorless oil. Rf 0.3 (20% EtOAc/petrol); nmax
(CHCl3)/cmꢂ1 2941, 2862, 1732, 1586, 1496, 1455, 1448, 1374, 1352,
1324, 1312, 1288, 1146, 1128, 1083, 1035, 1009, 982, 908, 867; dH
(400 MHz; CDCl3) 7.63e7.57 (3H, m), 7.44e7.40 (2H, m), 7.38e7.34
(3H, m), 7.32e7.26 (2H, m), 5.08 (1H, s), 4.86e4.80 (1H, m),
1.85e1.75 (2H, m), 1.74e1.65 (2H, m), 1.55e1.46 (1H, m), 1.45e1.23
(5H, m); dC (100 MHz; CDCl3) 164.3 (C), 136.6 (C), 134.2 (CH), 130.4
3.3.6. Cyclohexyl-2-phenyl-2-tosylacetate, 3b. Following general
flow method B, tosylhydrazone 1b gave, after purification by col-
umn chromatography (10% EtOAc/petrol) compound 3b (75 mg,
81%) as pale yellow needles, mp 127e128 ꢀC. Rf 0.8 (50% EtOAc/
petrol); nmax (CHCl3)/cmꢂ1 2935, 2861, 1732, 1597, 1496, 1331, 1193,
1183, 1143, 1128, 1083, 1035, 1010, 927, 865; dH (400 MHz; CDCl3)
7.49e7.46 (2H, m), 7.38e7.34 (3H, m), 7.31e7.27 (2H, m), 7.21 (2H, d,
J 8.0), 5.06 (1H, s), 4.84 (1H, tt, J 8.8, 4.4), 2.41 (3H, s), 1.85e1.75 (2H,